Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for Post-HSCT Thrombocytopenia
NCT01980030Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2013
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in Thrombocytopenia, sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2013; status: completed.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01980030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01980030.